Anavex Life Sciences
AVXL
#7722
Rank
โ‚น32.28 B
Marketcap
โ‚น361.30
Share price
1.52%
Change (1 day)
-67.84%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -โ‚น46.61

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -โ‚น48.65. In 2024 the company made an earnings per share (EPS) of -โ‚น46.85 an increase over its 2023 EPS that were of -โ‚น54.06.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น46.61-0.52%
2024-โ‚น46.85-13.33%
2023-โ‚น54.06-3.23%
2022-โ‚น55.8614.81%
2021-โ‚น48.6520%
2020-โ‚น40.54-16.67%
2019-โ‚น48.6538.46%
2018-โ‚น35.1418.18%
2017-โ‚น29.73-21.43%
2016-โ‚น37.84-35.38%
2015-โ‚น58.56-36.27%
2014-โ‚น91.90112.5%
2013-โ‚น43.25-58.62%
2012-โ‚น104.51-0%
2011-โ‚น104.51-29.27%
2010-โ‚น147.7651.85%
2009-โ‚น97.31-0%
2008-โ‚น97.31237.5%
2007-โ‚น28.83
2006N/A-100%
2005-โ‚น3.60499.97%
2004-โ‚น0.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น215.34-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น4.50-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น90.10-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น2,694 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA